Frontline: Surgery to remove the tumor is often considered, sometimes followed by chemotherapy or radiation to reduce ...
Updated NCCN Clinical Practice Guidelines in Oncology now recognize that MammaPrint and BluePrint testing can help identify a ...
Receiving a diagnosis of squamous cell carcinoma (SCC) can be an overwhelming experience, but it is important to remember that you are not alone. SCC is one of the most common forms of skin cancer ...
The U.S. Food and Drug Administration (FDA) has approved Guardant360 CDx as a companion diagnostic to identify patients with ...
Gainor highlighted that anyone can develop lung cancer, including people who have never smoked, and addressed the stigma that ...
For Ashliann Mazeika, a diagnosis at 24 led to a decade-long treatment journey affirmed by the Breast Cancer Index test. For ...
The FDA's breakthrough therapy designation facilitates accelerated development and regulatory review for therapies showing ...
Sofetabart mipitecan received FDA breakthrough therapy designation for platinum-resistant ovarian cancer after prior ...
Differentiating palliative care from hospice is crucial; palliative care focuses on holistic treatment, while hospice ...
The FDA granted orphan drug designation to zavabresib, an investigational therapy for the treatment of myelofibrosis, a rare ...
Cancer survivors' follow-up frequency depends on cancer type, treatment response, and individual factors, including insurance coverage. Recent CT results showed slightly increased mesenteric nodes, ...
When San Francisco-based surgeon Dr. Anne Peled decided to undergo a sensation-preserving mastectomy following her second ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results